Citius Initiates Mino-Lok™ Phase 3 Trial
Go back to Citius Initiates Mino-Lok™ Phase 3 Trial| (NASDAQ: CTXR) | Delayed: 0.76 +0.03 (4.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.73 | 52 Week High | $2.50 | |||
| Open | $0.75 | 52 Week Low | $0.40 | |||
| Day High | $0.79 | P/E | N/A | |||
| Day Low | $0.73 | EPS | $0.00 | |||
| Volume | 688,359 | |||||
| Medspas of America, Inc. New (NASDAQ: MEDP) | Delayed: 578.50 -3.45 (0.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $581.95 | 52 Week High | $35.58 | |||
| Open | $581.95 | 52 Week Low | $26.54 | |||
| Day High | $586.28 | P/E | N/A | |||
| Day Low | $571.74 | EPS | $0.00 | |||
| Volume | 220,618 | |||||
